Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
26.12
+0.42 (1.63%)
May 14, 2026, 4:00 PM EDT - Market closed
Enovis Revenue
Enovis had revenue of $589.15M in the quarter ending April 3, 2026, with 5.43% growth. This brings the company's revenue in the last twelve months to $2.28B, up 5.96% year-over-year. In the year 2025, Enovis had annual revenue of $2.25B with 6.66% growth.
Revenue (ttm)
$2.28B
Revenue Growth
+5.96%
P/S Ratio
0.66
Revenue / Employee
$292,023
Employees
7,802
Market Cap
1.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.25B | 140.43M | 6.66% |
| Dec 31, 2024 | 2.11B | 400.42M | 23.45% |
| Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
| Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
| Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
| Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
| Dec 31, 2019 | 3.33B | 1.13B | 51.73% |
| Dec 31, 2018 | 2.19B | 255.80M | 13.20% |
| Dec 31, 2017 | 1.94B | -1.25B | -39.19% |
| Dec 31, 2016 | 3.19B | -248.60M | -7.24% |
| Dec 31, 2015 | 3.43B | -1.19B | -25.74% |
| Dec 31, 2014 | 4.62B | 417.27M | 9.92% |
| Dec 31, 2013 | 4.21B | 293.35M | 7.50% |
| Dec 31, 2012 | 3.91B | 3.22B | 464.45% |
| Dec 31, 2011 | 693.39M | 151.41M | 27.94% |
| Dec 31, 2010 | 541.99M | 16.96M | 3.23% |
| Dec 31, 2009 | 525.02M | -79.83M | -13.20% |
| Dec 31, 2008 | 604.85M | 98.55M | 19.46% |
| Dec 31, 2007 | 506.31M | 112.70M | 28.63% |
| Dec 31, 2006 | 393.60M | 48.13M | 13.93% |
| Dec 31, 2005 | 345.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.29B |
| Integra LifeSciences Holdings | 1.64B |
| Inspire Medical Systems | 915.25M |
| Neogen | 870.56M |
| Alphatec Holdings | 787.08M |
| Avanos Medical | 715.90M |
| UFP Technologies | 608.85M |
| Artivion | 458.69M |
ENOV News
- 6 days ago - Enovis price target raised to $36 from $35 at Evercore ISI - TheFly
- 6 days ago - Enovis price target lowered to $37 from $45 at Baird - TheFly
- 7 days ago - Enovis Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - Enovis reports Q1 adjusted EPS 89c, consensus 81c - TheFly
- 7 days ago - Enovis backs FY26 adjusted EPS view $3.52-$3.73, consensus $3.63 - TheFly
- 7 days ago - Enovis Announces First Quarter 2026 Results - GlobeNewsWire
- 27 days ago - Enovis assumed with an Outperform at William Blair - TheFly
- 4 weeks ago - Enovis price target lowered to $39 from $43 at BTIG - TheFly